RecruitingNCT05813093
Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
In TorontoDepressionDevice studyAges 20–65
Study directory
Back to overviewDepression studies
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
RecruitingNCT06511908
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
In BethesdaDepressionMedication studyAges 18–70
RecruitingNCT05952674
Treatment Resistant Depression and Vagus Nerve Stimulation
Multiple locations, including BordeauxDepressionDevice studyAges 18+
RecruitingNCT07422519
Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression
What is this study about?
In BarcelonaThis study evaluates the effectiveness of mindfulness for people with depression.
DepressionMedication studyAges 18–74
Not Yet RecruitingNCT06881030
Comparison of Different Acceleration Modes of Transcranial Magnetic Stimulation
What is this study about?
This study evaluates the effectiveness of transcranial magnetic stimulation for people with depression.
This study isn't recruiting yet.
Location not clearly listedDepressionInterventional studyAges 18–45
Not Yet RecruitingNCT07247006
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
This study isn't recruiting yet.
In RochesterDepressionMedication studyAges 18+
Not Yet RecruitingNCT07373535
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
This study isn't recruiting yet.
In MontrealDepressionMedication studyAges 21+
Enrolling By InvitationNCT06633263
Combined Effect of TCC-I and BATD on Depressive Symptoms and Insomnia
This study is by invitation only.
In LiègeDepressionBehavioural studyAges 18–67
Not Yet RecruitingACTRN12610000710022
An 8 week placebo controlled study investigating the role of adjunctive bioactive lipids specifically; docosahexaenoic acid (DHA) versus eicosapentaenoic acid (EPA) in Major Depressive Disorder - with a 6 week open label extension of DHA in patients aged 18-65years.
This study isn't recruiting yet.
Location not clearly listedDepressionInterventional studyAges 18–65
RecruitingNCT07065240
SPT-300 (GlyphAllo) for depression
What is this study about?
Multiple locations, including ChinoResearchers are comparing SPT-300 and placebo to find out how the approaches affect depression symptoms in adults with depression.
DepressionMedication studyAges 18–65
RecruitingNCT06968390
Accelerated TMS for Perinatal Depression
In BostonDepressionDevice studyAges 18–55
RecruitingNCT06728774
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
In PortlandDepressionBehavioural studyAges 18+
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.